Back to Browse Journals » Clinical Ophthalmology » Volume 1 » Issue 4

Development of the anti-VEGF aptamer to a therapeutic agent for clinical ophthalmology

Authors Cleber A Trujillo, Arthur A Nery, Janaí­na M Alves, Antonio H Martins, Henning Ulrich

Published 15 February 2008 Volume 2007:1(4) Pages 393—402

Cleber A Trujillo1, Arthur A Nery1, Janaína M Alves2, Antonio H Martins1, Henning Ulrich1

1Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brazil; 2Departamento de Neurologia Experimental, Universidade Federal de São Paulo, São Paulo, Brazil

Abstract: Age-related macular degeneration (AMD) is the main cause of loss of sight in the world and is characterized by neovascularization of the macula. The factors producing choroidal vascularization involve various growth factors, including the vascular endothelial growth factor (VEGF165). In this context, the systematic evolution of ligands by exponential enrichment (SELEX) became a tool for developing new therapeutic agents for AMD treatment. The SELEX is a combinatorial oligonucleotide library-based in vitro selection approach in which DNA or RNA molecules (aptamers) are identified by their ability to bind their targets with high affinity and specificity. Recently, the use of the SELEX technique was extended to isolate oligonucleotide ligands for a wide range of proteins of clinical importance. For instance, Pegaptanib sodium, a 28-nucleotide polyethylene glycol RNA aptamer that selectively binds to VEGF165 and inhibits angiogenesis, was approved by the Food and Drug Administration for the treatment of wet AMD, thereby providing significant benefits to a great number of patients with minimal adverse effects.

Keyword: anti-VEGF aptamer, pegaptanib, age-related macular degeneration

Download Article [PDF] 

Readers of this article also read:

Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US

Marrett E, Zhao C, Zhang NJ, Zhang Q, Ramey DR, Tomassini JE, Tershakovec AM, Neff DR

Vascular Health and Risk Management 2014, 10:237-246

Published Date: 25 April 2014

Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs

Binjawadagi B, Dwivedi V, Manickam C, Ouyang K, Wu Y, Lee LJ, Torrelles JB, Renukaradhya GJ

International Journal of Nanomedicine 2014, 9:679-694

Published Date: 24 January 2014

Anti-αvβ3 antibody guided three-step pretargeting approach using magnetoliposomes for molecular magnetic resonance imaging of breast cancer angiogenesis

Yan C, Wu Y, Feng J, Chen W, Liu X, Hao P, Yang R, Zhang J, Lin B, Xu Y, Liu R

International Journal of Nanomedicine 2013, 8:245-255

Published Date: 11 January 2013

Nimodipine-loaded mixed micelles: formulation, compatibility, pharmacokinetics, and vascular irritability study

Song X, Jiang Y, Ren CJ, Sun X, Zhang Q, Gong T, Zhang ZR

International Journal of Nanomedicine 2012, 7:3689-3699

Published Date: 13 July 2012

Foveal and parafoveal retinal thickness in healthy pregnant women in their last trimester

Demir M, Oba E, Can E, Odabasi M, Tiryaki S, Ozdal E, Sensoz H

Clinical Ophthalmology 2011, 5:1397-1400

Published Date: 23 September 2011

Common complications of deep lamellar keratoplasty in the early phase of the learning curve

Hosny M

Clinical Ophthalmology 2011, 5:791-795

Published Date: 10 June 2011

Central corneal thickness and intraocular pressure in the Cameroonian nonglaucomatous population

André Omgbwa Eballe, Godefroy Koki, Augustin Ellong, et al

Clinical Ophthalmology 2010, 4:717-724

Published Date: 5 July 2010


Erhardt L, Moller R, Puig JC. 2007

Vascular Health and Risk Management 2008, 4:741-741

Published Date: 6 June 2008

Rheumatic heart disease: 15 years of clinical and immunological follow-up

Roney O Sampaio, Kellen C Fae, Lea MF Demarchi, Pablo MA Pomerantzeff, Vera D Aiello, et al

Vascular Health and Risk Management 2007, 3:1007-1017

Published Date: 15 January 2008

Diabetic retinopathy

Fadia T Shaya, Mohammad Aljawadi

Clinical Ophthalmology 2007, 1:259-265

Published Date: 15 December 2007